Dr Reddys Laboratories Ltd
RDY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001135951
No open-market purchases or sales by Dr Reddys Laboratories Ltd insiders were filed in the last 90 days; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.82B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Dr Reddys Laboratories Ltd as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 224
- +12 vs. Q3 2023
- Shares held
- 23.5M
- +1.76M (+8.1%) vs. Q3 2023
- Total value
- $1.64B
- +$130.9M (+8.7%) vs. Q3 2023
- New holders
- 37
- 82 more added
- Sold out
- 25
- 66 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RDY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $1.82B |
| Q1 2026 | 249 | $1.67B |
| Q4 2025 | 237 | $1.50B |
| Q3 2025 | 228 | $1.50B |
| Q2 2025 | 243 | $1.62B |
| Q1 2025 | 246 | $1.45B |
| Q4 2024 | 248 | $1.87B |
| Q3 2024 | 229 | $1.79B |
| Q2 2024 | 222 | $1.84B |
| Q1 2024 | 231 | $1.73B |
| Q4 2023 | 224 | $1.64B |
| Q3 2023 | 213 | $1.51B |
| Q2 2023 | 194 | $1.31B |
| Q1 2023 | 191 | $1.07B |
| Q4 2022 | 162 | $849.9M |
| Q3 2022 | 151 | $856.7M |
| Q2 2022 | 149 | $866.2M |
| Q1 2022 | 146 | $923.9M |
| Q4 2021 | 148 | $1.07B |
| Q3 2021 | 150 | $1.11B |
| Q2 2021 | 161 | $1.35B |
| Q1 2021 | 161 | $1.13B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Dr Reddys Laboratories Ltd; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 129,361 | $9.00M | 0.01% | −2,200−1.7% | Reduced |
| Wellington Management Group LLP | 144,445 | $10.1M | 0.00% | +3,291+2.3% | Added |
| Qube Research & Technologies Ltd | 158,206 | $11.0M | 0.02% | −16,192−9.3% | Reduced |
| Assenagon Asset Management S.A. | 196,146 | $13.6M | 0.04% | +158,141+416.1% | Added |
| Ameriprise Financial Inc | 198,150 | $13.8M | 0.00% | −236,304−54.4% | Reduced |
| Fisher Asset Management, LLC | 205,280 | $14.3M | 0.01% | +114,630+126.5% | Added |
| Acadian Asset Management LLC | 211,321 | $14.7M | 0.06% | −58,939−21.8% | Reduced |
| Mondrian Investment Partners LTD | 218,961 | $15.2M | 0.24% | +2,816+1.3% | Added |
| Schroder Investment Management Group | 266,653 | $18.6M | 0.02% | +116,488+77.6% | Added |
| Grantham, Mayo, Van Otterloo & Co. LLC | 329,132 | $22.9M | 0.10% | +78,344+31.2% | Added |
| Lazard Asset Management LLC | 347,083 | $24.1M | 0.03% | +40,997+13.4% | Added |
| GQG Partners LLC | 436,951 | $30.4M | 0.06% | −285,497−39.5% | Reduced |
| Bank of America Corp | 562,553 | $39.1M | 0.00% | −8,755−1.5% | Reduced |
| State Street Corp | 742,919 | $51.7M | 0.00% | +24,415+3.4% | Added |
| Man Group plc | 765,193 | $53.2M | 0.15% | – | – |
| Morgan Stanley | 818,552 | $57.0M | 0.01% | +81,752+11.1% | Added |
| Dimensional Fund Advisors LP | 829,310 | $57.7M | 0.02% | +1,819+0.2% | Added |
| Vanguard Group Inc | 1,038,258 | $72.2M | 0.00% | −9,894−0.9% | Reduced |
| Aikya Investment Management Ltd | 1,096,573 | $75.8M | 33.82% | +1,096,573 | New |
| Robeco Institutional Asset Management B.V. | 1,725,380 | $120.1M | 0.29% | +52,254+3.1% | Added |
| Goldman Sachs Group Inc | 1,837,163 | $127.8M | 0.03% | −140,385−7.1% | Reduced |
| Renaissance Technologies LLC | 1,860,795 | $129.5M | 0.20% | +25,371+1.4% | Added |
| Royal Bank of Canada | 2,219,807 | $154.5M | 0.04% | +72,491+3.4% | Added |
| BlackRock Inc. | 3,001,420 | $208.8M | 0.01% | +517,270+20.8% | Added |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −47,053−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −29,935−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −28,147−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −19,702−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −17,530−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −13,049−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,445−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −11,417−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,675−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −7,458−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −6,701−100.0% | Sold out |
| KLR Investment Advisors, LLC | 0 | $0 | 0.00% | −6,605−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −4,870−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −4,582−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −4,115−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −3,690−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −1,613−100.0% | Sold out |
| FSC Wealth Advisors, LLC | 0 | $0 | 0.00% | −604−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −595−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −315−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Stonebridge Capital Advisors LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Thomas J. Herzfeld Advisors, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Advisor Partners II, LLC | – | – | – | – | Not filed |